Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Q2 Revenue Grew, Though Robotic Sales Shriveled

This update serves to correct that Beckman Coulter reported net earnings, not net losses, during the second quarter.


NEW YORK  July 31 - Beckman Coulter today posted a modest uptick in second-quarter revenue atop increased R&D spending and increased earnings. However, sale of lab-automation and genetic-analysis tools shrank.


Total revenue for the period ended June 30 increased to $551.8 million from $516.1 million one year ago. Receipts from lab-automation and genetic analysis instruments in the quarter fell more than 10 percent to $39.2 million year over year, while centrifuge and analytical-system sales increased by 1.9 percent to $69.7 million, Beckman said.


Second-quarter R&D spending increased to $48 million from $47.8 million during the same period one year ago. As a result, net income in the quarter grew to $52.2 million, or $.86 per share, from $41.9 million, or $.68 per share, for the same quarter 2002.


Beckman CEO John Wareham said In the third quarter, we expect sales to be up 7 percent to 8 percent. Sales of biomedical research products, which contains Beckman's lab-automation and genetic- and protein-analysis tools, should grow in the low single digits, he said.

"In biomedical research we are cautiously optimistic about R&D spending in the government funded and pharmaceutical sectors, but still bearish on biotechnology R&D spending," Wareham said in a statement.


He added that forthcoming new-product releases, like the ProteomeLab PF 2D, the ProteomeLab PA 800 protein-characterization system, and the CEQ 8800 genetic-analysis system, should aid sales growth in the second half.

Beckman said it had around $66.6 million in cash and cash equivalents as of June 30.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.